This webinar addressed the strategic role of health technology in the development, clinical translation, and industrial scalability of advanced therapies, including regenerative medicine and cell therapy. Its main objective was to identify synergies between industry, the clinical field, and regulatory bodies, analyzing the key challenges related to technology transfer, regulation, and industrialization that influence the sustainable adoption of these innovations within the healthcare system.
Through the different presentations, the session provided deeper insight into the challenges faced by the sector and highlighted how health technology acts as a key enabler for bringing advanced therapies from the laboratory to clinical practice and ultimately to large‑scale manufacturing.
Key highlights of the webinar:
- Increased visibility of the essential role of health technology in the development, validation, and industrialization of advanced therapies.
- Identification of major regulatory, technological, and industrial challenges associated with scaling these therapies.
- Strengthened dialogue among companies, clinicians, and regulators, fostering the detection of synergies between health technology and regenerative medicine.
The webinar established itself as a reference forum for moving towards a shared vision that drives innovation and ensures the sustainable clinical adoption of advanced therapies.
